Nail Psoriasis Treatment Device Study
Part of Skin clinical trials.
This study tests a medical device called PROXERA PSOMED 30 to see if it safely and effectively treats nail psoriasis (psoriasis affecting fingernails or toenails). If you have nail psoriasis, this trial may help determine whether this device works better than current treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with psoriasis and nail psoriasis for at least 6 months
- You are between 18 and 65 years old
- You are willing to sign a consent form and participate in the study
- You are not pregnant or breastfeeding
- You are not currently using most immunosuppressive medications or biologic drugs (certain exceptions apply)
- You are not using topical steroids, calcineurin inhibitors, or vitamin D creams on your nails during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicated nail patch to see if it can improve nail fragility, fungal infections (onychomycosis), or psoriasis that covers up to 75% of the nail. It might help if you have nail problems that haven't gotten better with other treatments.
This study tests a new prescription cream called roflumilast to see if it helps with both skin plaques and nail psoriasis. If you join, you'll apply the cream to affected areas and be monitored to see how well it works and if it's safe.
This study tests two medicated creams containing urea (a natural moisturizing ingredient) to treat psoriasis on the skin and on the palms and soles of the feet. The creams may help reduce flaking, scaling, and irritation in people with mild psoriasis.
This study uses photos of your fingernails to help tell psoriasis apart from other skin conditions. If you join, your nail pictures will be used to build a tool that could help doctors diagnose psoriasis faster and more accurately.
This trial studies how guselkumab works for people with long-lasting, more severe psoriasis and signs that may affect joints. It may help by improving psoriasis symptoms and possibly reducing related inflammation, while researchers track safety and outcomes.
This trial tests a new study drug (ZP9830) to see if it is safe and works well for people with plaque psoriasis. You would receive the treatment for 8 weeks, and the study will check how your skin responds.
Hear when a new Nail Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.